Stifel Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$9.2M Sell
97,059
-5,589
-5% -$504K 1.76% 5
2014
Q2
$8.82M Sell
102,648
-2,058
-2% -$157K 1.65% 6
2014
Q1
$7.31M Sell
104,706
-3,180
-3% -$252K 1.38% 11
2013
Q4
$9.12M Sell
107,886
-2,224
-2% -$176K 1.71% 5
2013
Q3
$8.49M Sell
110,110
-3,860
-3% -$271K 1.69% 5
2013
Q2
$6.67M Buy
+113,970
New +$6.86M 1.38% 16

Other funds holding CELG

Stifel Trust's CELG Position: Q3 2014 in Review

Stifel Trust reduced its Celgene Corp (CELG) stake by 5.4% in Q3 2014, selling an estimated $504K and leaving 97,059 shares worth $9.2M. The position accounts for 1.76% of the portfolio, ranked #5.

Stifel Trust first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Stifel Trust held 97,059 shares of Celgene Corp worth $9.2M as of Q3 2014.
  • Stifel Trust sold 5,589 Celgene Corp shares in Q3 2014, an estimated $504K.
  • Celgene Corp made up 1.76% of Stifel Trust's portfolio in Q3 2014, its #5 holding.
  • Stifel Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Stifel Trust's 13F filing for Q3 2014, filed 14 Nov 2014.